Post by Alexion Pharmaceuticals, Inc.

As the International Society for Children's Bone Health (ICCBH) 2026 Conference comes to a close, we’re proud to have presented our latest research in #hypophosphatasia (HPP) and connected with leaders in the bone metabolism space to deepen understanding of the unmet needs of those living with HPP. Building upon our established #RareDisease expertise, we are working to ensure that scientific insights translate into meaningful improvements for children and their loved ones affected by this disease.